Immunopathogenesis and neurological manifestations associated to HTLV-1 infection

Souza, Anselmo; Tanajura, Davi; Toledo-Cornell, Cristina; Santos, Silvane; Carvalho, Edgar Marcelino de.
Rev. Soc. Bras. Med. Trop ; 45(5): 545-552, Sept.-Oct. 2012. ilus, tab
Artículo en Inglés | LILACS | ID: lil-656206

Documentos relacionados

  1. Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection.
  2. Cognitive deficits in HTLV-1 patients.
  3. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
  4. Sensory neuronopathy heralding human T cell lymphotropic virus type I myelopathy.
  5. Refining the risk of HTLV-1-associated myelopathy in people living with HTLV-1: identification of a HAM-like phenotype in a proportion of asymptomatic carriers.
  6. Evaluation of iron, ferritin, copper, and ceruloplasmin along with proviral load in human T lymphotropic virus type 1-associated myelopathy.
  7. Signs and symptoms of human T-lymphotropic virus 1 and 2 infections in paediatric patients.
  8. Could Cesarean Delivery Help Prevent Mother-to-Child Transmission of Human T-Lymphotropic Virus Type 1?
  9. Patient research priority setting partnership in human T-cell lymphotropic virus type I.
  10. T helper type 9 cell response and its role in the neurological clinic of patients with Human T-lymphotropic virus 1.